Cover Image

Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies

Carbonic anhydrases IX and CAXII (CAIX/CAXII) are transmembrane zinc metalloproteins that catalyze a very basic but crucial physiological reaction: the conversion of carbon dioxide into bicarbonate with a release of the proton. CA, especially CAIX and CAXII isoforms gained the attention of many rese...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mateusz Kciuk (Author), Adrianna Gielecińska (Author), Somdutt Mujwar (Author), Mariusz Mojzych (Author), Beata Marciniak (Author), Rafał Drozda (Author), Renata Kontek (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
by: Chiara Testa, et al.
Published: (2022)

Exploring the Comprehensive Neuroprotective and Anticancer Potential of Afzelin
by: Mateusz Kciuk, et al.
Published: (2024)

Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase
by: Mikhail Krasavin, et al.
Published: (2020)

Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
by: Nora Astrain-Redin, et al.
Published: (2023)

Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms
by: Wagdy M. Eldehna, et al.
Published: (2022)

Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII
by: Sara Seršen, et al.
Published: (2019)

Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms
by: Melissa D'Ascenzio, et al.
Published: (2017)

Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro Studies
by: Gianmarco Gualtieri, et al.
Published: (2023)

Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII
by: Tarfah Al-Warhi, et al.
Published: (2022)

Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors
by: P. V. Sri Ramya, et al.
Published: (2017)

Aryl derivatives of 3H-1,2-benzoxaphosphepine 2-oxides as inhibitors of cancer-related carbonic anhydrase isoforms IX and XII
by: Anastasija Balašova, et al.
Published: (2023)

Therapeutic Potential of Plant-Derived Compounds and Plant Extracts in Rheumatoid Arthritis-Comprehensive Review
by: Mateusz Kciuk, et al.
Published: (2024)

Vanillin enones as selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII. The out of the active site pocket for the design of selective inhibitors?
by: Leonardo E. Riafrecha, et al.
Published: (2021)

2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms
by: Lisa Sequeira, et al.
Published: (2023)

7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

Synthesis, computational studies and assessment of in vitro inhibitory activity of umbelliferon-based compounds against tumour-associated carbonic anhydrase isoforms IX and XII
by: Francesca Mancuso, et al.
Published: (2020)

4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies
by: Hossam Nada, et al.
Published: (2022)

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX
by: Anne E.G. Lenferink, et al.
Published: (2021)

A class of carbonic anhydrase IX/XII - selective carboxylate inhibitors
by: Rakia Abd Alhameed, et al.
Published: (2020)

Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives
by: Rita Meleddu, et al.
Published: (2021)

Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse Macrophages
by: Emanuela Berrino, et al.
Published: (2021)

Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies
by: Ciro Milite, et al.
Published: (2019)

Transmembrane carbonic anhydrase isozymes IX and XII in the female mouse reproductive organs
by: Tomas Eija, et al.
Published: (2004)

Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
by: Mehmet Onyılmaz, et al.
Published: (2022)

Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II
by: Jekaterīna Ivanova, et al.
Published: (2023)

Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII
by: Andrea Angeli, et al.
Published: (2017)

3H-1,2-Benzoxaphosphepine 2-oxides as selective inhibitors of carbonic anhydrase IX and XII
by: Aleksandrs Pustenko, et al.
Published: (2023)

Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors
by: Zainab M. Elsayed, et al.
Published: (2023)

In Silico Identification and Biological Evaluation of Antioxidant Food Components Endowed with Human Carbonic Anhydrase IX and XII Inhibition
by: Giosuè Costa, et al.
Published: (2020)

Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation
by: Mohamed A. Abdelrahman, et al.
Published: (2020)

Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies
by: Emma Baglini, et al.
Published: (2021)

Pyrrolyl and Indolyl α-γ-Diketo Acid Derivatives Acting as Selective Inhibitors of Human Carbonic Anhydrases IX and XII
by: Davide Ialongo, et al.
Published: (2023)

Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII
by: Ashraf K. El-Damasy, et al.
Published: (2023)

Synthesis and biological evaluation of new 3-substituted coumarin derivatives as selective inhibitors of human carbonic anhydrase IX and XII
by: Shaik Mahammad Ghouse, et al.
Published: (2023)

Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents
by: Mikhail Krasavin, et al.
Published: (2020)

New Sulfamethoxazole Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Cytotoxic Activity and Molecular Modeling
by: Mohamed A. Abdelgawad, et al.
Published: (2022)

Molecular Modeling, Synthesis, and preliminary pharmacological evaluation of New Sulfonamide Derivatives as Selective Carbonic Anhydrase XII and IX inhibitors (Research)
by: Samer Tareq Jasim, et al.
Published: (2024)

Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties
by: Tuba Tekeli, et al.
Published: (2023)

Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation
by: Benedetta Fois, et al.
Published: (2020)

Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties
by: Kalyan K. Sethi, et al.
Published: (2021)